Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Share-based Compensation (2022 - 2025)

Historic Share-based Compensation for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $291717.0.

  • CervoMed's Share-based Compensation rose 755.93% to $291717.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 2065.13%. This contributed to the annual value of $1.4 million for FY2024, which is 24485.07% up from last year.
  • According to the latest figures from Q3 2025, CervoMed's Share-based Compensation is $291717.0, which was up 755.93% from $497015.0 recorded in Q2 2025.
  • In the past 5 years, CervoMed's Share-based Compensation ranged from a high of $578581.0 in Q2 2024 and a low of $62252.0 during Q2 2023
  • Its 4-year average for Share-based Compensation is $245525.7, with a median of $271215.0 in 2024.
  • Per our database at Business Quant, CervoMed's Share-based Compensation crashed by 7761.77% in 2023 and then soared by 82941.75% in 2024.
  • Quarter analysis of 4 years shows CervoMed's Share-based Compensation stood at $80988.0 in 2022, then skyrocketed by 103.7% to $164972.0 in 2023, then soared by 104.71% to $337711.0 in 2024, then dropped by 13.62% to $291717.0 in 2025.
  • Its Share-based Compensation stands at $291717.0 for Q3 2025, versus $497015.0 for Q2 2025 and $361167.0 for Q1 2025.